Active, not recruiting |
: Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants
: Mumps
: 2016-02-23
: - Biological: investigational live attenuated mumps vaccine
|
Not yet recruiting |
: Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants
: Epidemic Parotitis,Mumps
: 2017-04-17
: - Biological: ≥3.0 lgCCID50/mlbut <3.5lgCCID50/ml Live Attenuated
|
Completed |
: A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children
: The Study Focused on the Safety of Attenuated Mumps Vaccine (Human Diploid Cell) Against Mumps in Chinese Adults, Children and Infants.
: 2012-10-22
: - Biological: 3.50±0.25logCCID50/ml
|
Completed |
: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age
: Measles; Mumps; Rubella
: 2014-07-03
: - Biological: GSK Biologicals measles, mumps and rubella vaccine live (GSK 209
|
Completed |
: Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations
: - Measles
- Mumps
- Rubella
: 2013-01-21
: Biological: MMR Vaccine Administration of MMR Vaccine by Bio-Manguinhos or MMR Vaccine by GlaxoSmithKlin
|
Completed |
: Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older
: - Rubella
- Mumps
- Measles
: 2014-02-06
: - Biological: Priorix® 1 do
|
Completed |
: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age
: - Rubella
- Mumps
- Measles
: 2012-06-14
: - Biological: Priorix® Sing
|
Completed |
: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life
: - Measles
- Mumps
- Rubella
: 2012-09-06
: - Biological: GSK Biologicals measles, mumps and rubella vaccine live (GSK 209
|
Completed |
: Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)
: - Mumps
- Rubella
- Measles
: 2013-06-07
: Biological: MMR (Mumps, Measles and Rubella) MMR (Mumps, Measles and Rubella)
|
Completed |
: A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)
: - Measles
- Mumps
- Rubella
: 2004-09-22
: - Biological: Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vacc
|